G1 Therapeutics: Q2 Earnings Insights

G1 Therapeutics: Q2 Earnings Insights


G1 Therapeutics GTHX reported its Q2 earnings results on Wednesday, August 3, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.


G1 Therapeutics beat estimated earnings by 9.8%, reporting an EPS of $-0.92 versus an estimate of $-1.02.

Revenue was up $3.97 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.18 which was followed by a 4.55% drop in the share price the next day.

Here's a look at G1 Therapeutics's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.97 -1.03 -1 -0.97
EPS Actual -1.15 -0.94 -1 -0.94
Revenue Estimate 6.69M 5.68M 5.18M 2.59M
Revenue Actual 6.90M 5.80M 4.86M 6.60M

To track all earnings releases for G1 Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarningsNews